Clinical Trial: Safety and Efficacy of B/F/TAF in Pregnancy

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07666386) titled 'Safety and Efficacy of B/F/TAF in Pregnancy' on June 09.

Brief Summary: This is a prospective, multicenter, observational study designed to evaluate the effectiveness and safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in pregnant women living with HIV. Given the limited prospective data on B/F/TAF use during early pregnancy, this study aims to address the evidence gap by observing women who are on B/F/TAF for at least six months with sustained viral suppression (HIV RNA <50 copies/mL) and are within the first trimester. Participants will continue B/F/TAF throughout pregnancy and up to 12 weeks postpartum per rou...